A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants

NCT04263142 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: GSK3640254 Tablet
DRUG: GSK3640254 Capsule

Sponsor

ViiV Healthcare